Google Alert - "anti diabetes"

	"anti diabetes" As-it-happens update ⋅ June 13, 2016
	NEWS
	FiercePharma Positive results from pivotal Phase III clinical trials with iGlarLixi presented at the American ... EconoTimes In the LixiLan-O trial, 1,170 patients with type 2 diabetes inadequately controlled on oral anti-diabetes medication received treatment with iGlarLixi, ... Flag as irrelevant

You have received this email because you have subscribed to Google Alerts. Unsubscribe

Receive this alert as RSS feed

Send Feedback